News
Wegovy tipped to become UK’s top weight loss drug after Mounjaro price hike
A week on from increases in the cost of Eli Lilly’s weight loss drug Mounjaro (tirzepatide), weight loss medication provider CheqUp has reported a dramatic 27-fold surge in sales of Novo Nordisk’s Wegovy/Ozempic (semaglutide) in the UK.
In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...
Results from a late-stage trial of Eli Lilly's experimental weight-loss pill were disappointing, sending shares of the ...
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.
A popular diabetes and weight loss drug could be on the horizon in pill form as drugmaker Eli Lilly released results of an experimental GLP-1 phase three trial. Mounjaro, which is marketed ...
Trump administration demands lower U.S. prices on drugs like Mounjaro, forcing the pharmaceutical company to raise them in ...
Eli Lilly will raise the UK list price of its weight-loss and type 2 diabetes treatment Mounjaro by up to 170% to be in line ...
Eli Lilly looks attractively valued, with P/E ratios well below historical averages and robust momentum in Zepbound and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback